Fennec Pharmaceuticals Inc. (FENC) Financials
FENC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 19.0 million | 29.6 million |
2023-06-30 | 19.4 million | 29.2 million |
2023-03-31 | 21.8 million | 29.2 million |
2022-12-31 | 26.9 million | 29.5 million |
FENC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.7 million | 865000 |
2023-06-30 | -3.9 million | 2.5 million |
2023-03-31 | -5.6 million | 1.1 million |
2022-12-31 | -6.8 million | 827000 |
FENC Net Income
No data available :(
FENC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 12.4 million | - | 28000 |
2023-06-30 | 15.0 million | 24.7 million | - |
2023-03-31 | 18.4 million | 24.7 million | - |
2022-12-31 | 23.8 million | - | - |
FENC Shares Outstanding
FENC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 12000 | 3.8 million | 3.4 million |
2023-06-30 | - | 8000 | 5.5 million | 2.3 million |
2023-03-31 | - | 4000 | 4.3 million | 2.5 million |
2022-12-31 | - | 117000 | 4.7 million | 2.8 million |
FENC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 6.5 million | 331000 |
2023-06-30 | 3.3 million | 148000 |
2023-03-31 | 1.7 million | 95000 |
2022-12-31 | 1.5 million | 86000 |
FENC
Price: $9.23
52 week price:
Earnings Per Share: -0.75 USD
P/E Ratio: -12.53
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 138134
Ebitda: -2.2 millionMarket Capitalization: 289.1 million